Skip to main content

Effects of Nifedipine on Blood Pressure, Arterial Compliance and Left Ventricular Mass in Elderly Patients with Isolated Systolic Hypertension

  • Conference paper
How Should Elderly Hypertensive Patients Be Treated?

Summary

The aim of this study was to evaluate the effects of acute and chronic administration of slow-release nifedipine (SRN) on blood pressure (BP), aortic index (AI), average wall stress (AWS), left ventricular mass (LVM), and other hemodynamic parameters in elderly patients with isolated systolic hypertension (ISH) (systolic blood pressure [SBP] > 175 mmHg). We studied 10 patients (mean age 73.7 ± 5.6 years) in which after a washout period, in basal conditions, 3 h after the administration of SRN (20 mg), and 180 days after chronic therapy (40 mg daily), we evaluated the changes of BP, HR, AI, AWS, LVM, and other parameters obtained by means of echocardiography. After SRN we observed a significant decrease of SBP both in acute (P < 0.005 in supine and P < 0.0125 in upright position) and in chronic (P < 0.0005 in supine and P < 0.005 in upright position) therapies and a slight decrease of DBP, whereas HR did not show great changes. AI decreased significantly (P < 0.01 in acute and in chronic) as well as did systemic vascular resistance (P < 0.025 in acute and P < 0.01 in chronic). Moreover, we observed a significant diminution of AWS (P < 0.01) and LVM (P < 0.01) after 180 days of treatment. These results seem to show that SRN is useful in elderly patients with ISH, because it produces an improvement both of arterial compliance and of left ventricle function parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kannel WB, Gordon T (1978) Evaluation of cardiovascular risk in the elderly: The Framingham Study. Bull NY Acad Med 54: 573–591

    CAS  Google Scholar 

  2. Subcommittee on Risk Factors and Stroke of the Stroke Council (1987) Risk factors in stroke. AHA Focus Series. American Heart Association. Stroke 3 (1): 9–14

    Google Scholar 

  3. Kannel WB, Dauber TR, McGee DL (1980) Perspectives on systolic hypertension: The Framingham Study. Circulation 61: 1179–1182

    Article  PubMed  CAS  Google Scholar 

  4. Simon ACh. Safer ME, Levenson JA, London GM, Levy BI, Chau NPh (1979) An evaluation of large arteries compliance in man. AM J Physiol 237: 550–554

    Google Scholar 

  5. Safar ME, Laurent St, Asmar RE, Savafian A, London GM (1987) Systolic hypertension in patients with arteriosclerosis obliterans of the lower limbs. Angiology 4: 287–295

    Article  Google Scholar 

  6. Ben-Ishay D, Leibel B, Stessman J (1986) Calcium channel blockers in the management of hypertension in the elderly. Am J Med 81 (Suppl VIA): A30–34

    Article  PubMed  CAS  Google Scholar 

  7. Anonymous (1985) Treatment of hypertension in the over-60s. Lancet 1: 1369–1370 (editorial)

    Google Scholar 

  8. Laragh JH, Bühler FR, Chobanian A, Hansson L, Zachariah PK (1987) Calcium antagonists in hypertension: update 1986. J Cardiovasc Pharmacology 9 (Suppl IV): 1–3

    Google Scholar 

  9. Zanchetti A (1987) Role of calcium antagonists in systemic hypertension. Am J Cardiol 59: 130–136

    Article  Google Scholar 

  10. Strano A, Novo S, Modica R, Nardi E, Donia G (1986) Hemodynamic effects of acute administration of slow-release nifedipine in elderly patients with systolic hypertension. Am J Nephrol 6 (Suppl I): 91–94

    Article  PubMed  Google Scholar 

  11. MacGregor GA (1986) Hypertension. In: Krebs R (ed) Treatment of cardiovascular diseases by Adalat (nifedipine). Schattauer, Stuttgart New York, pp 231–258

    Google Scholar 

  12. Kirkendall WM, Burton AC, Epstein FH, Fresis ED (1967) Recomendations for human blood pressure determination by sphygmomanometer. Circulation 36: 980–987

    Article  PubMed  CAS  Google Scholar 

  13. Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recomendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072–1083

    Article  PubMed  CAS  Google Scholar 

  14. Quinones MA, Pickering E, Alexander JK (1978) Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume. Chest 74: 59–65

    Article  PubMed  CAS  Google Scholar 

  15. Eaton LW, Maughan WL, Shoukas AA, Weiss JL (1979) Accuration volume determination in the isolated ejecting canine left ventricle by two-dimensional echocardiography. Circulation 60: 320–327

    Article  PubMed  CAS  Google Scholar 

  16. Tarazi RC, Magrini F, Dustan HP (1975) The role of aortic distensibility in hypertension. In: Miller P, Safar MD (eds) International symposium on hypertension. Boehringer Ingelheim, Monaco, pp 133–138

    Google Scholar 

  17. Novo S, Licata G, Pinto A, Davi G, Strano A (1983) Haemodynamic effects of an antihypertensive combination between labetalol and chlortalidone administered for 6 months. J Hypertens 1 (Suppl II): 353–360

    Google Scholar 

  18. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613–618

    Article  PubMed  CAS  Google Scholar 

  19. Martin MA, Fieller NRJ (1979) Echocardiography in cardiovascular drug assessment. Br Heart J 41: 536–543

    Article  PubMed  CAS  Google Scholar 

  20. Simon ACh, Levenson JA, Safar ME (1985) Hemodynamic mechanisms of and therapeutic approach to systolic hypertension. J Cardiovasc Pharmacol 7: 22–27

    Article  Google Scholar 

  21. Fleckenstein A, Frey M, Fleckenstein-Grün G (1986) Antihypertensive and arterial anticalcinotic effects of calcium antagonists. Am J Cardiol 57: 1–10

    Article  Google Scholar 

  22. Fleckenstein A (1988) Future prospects in calcium antagonist therapy: prevention of arteriosclerotic vascular damage. Abstract of Verapamil Satellite Symposium of the 25 Anniversary International Symposium on Calcium Antagonists in Hypertension, Basel, February 9–11, 1988. p3

    Google Scholar 

  23. Bouthier JD, DeLuca N, Safar ME, Simon ACh (1985) Cardiac hypertrophy and arterial distensibility in essential hypertension. Am Heart J 109: 1345–1352

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer Japan

About this paper

Cite this paper

Novo, S., Nardi, E., Noto, G., Licata, G., Strano, A. (1989). Effects of Nifedipine on Blood Pressure, Arterial Compliance and Left Ventricular Mass in Elderly Patients with Isolated Systolic Hypertension. In: Omae, T., Zanchetti, A. (eds) How Should Elderly Hypertensive Patients Be Treated?. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68340-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68340-7_18

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68342-1

  • Online ISBN: 978-4-431-68340-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics